Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Questions and Answers -- Ignore unavailable to you. Want to Upgrade?

To: zakaran who wrote (18)	1/19/1999 5:53:00 AM
From: Mike McFarland	Read Replies (1) \| Respond to of 30

No...but if you do a few keyword searches here on SI you may be able to unearth whether or not any of the biotechies went to their H&Q presentation. I would suggest refining a list of questions you may have, pose it to the thread...if there is one here or on yahoo, further refine your list...and then just write, email, or call the company. Most of us get halfway through our homework, but never get up the nerve to make the call. My guess is that you have something there that is pretty well known now after the run-up, and it is a momentum play now instead of a value pick...not my style, but momo is where the money has been going, so what do I know, heh heh. --Mike

To: zakaran who wrote (18)	1/19/1999 11:20:00 PM
From: John McCarthy	Read Replies (1) \| Respond to of 30

zakaran ... Excuse my intrusion .... I am not selling QLT as I am already long. I posted this page on Yahoo ... it is simply a list of links. My motive was to speed up the learning curve on QLT. messages.yahoo.com@m2.yahoo.com I have gone thru (success and failure) about 7 FDA thingies. i.e. Some of my biggest hurts have been Depo and Npro. I have also had a few successes. A thingie is that stage where we all hang out and try to determine ... (a) Is the data really good, clean data that the FDA won't ,in effect, say, do it again or whatever ... e.g. DEPO (b) If the data is good and clean, did the product really show efficacy. Biomatrix (Synvisc) was really a borderline call. Right now we are in limbo. It is my understanding that the first Peer Report on the Phase 3 results for Visudyne will come out in a May 9th conference in Orlando. I don't know when they will file. I don't know how long the FDA will take ... i.e. fast track AFTER they file. Lastly, today this came out ... but I am not really too worried about it ... timewise .. biz.yahoo.com One last thing ... when QLT released their news, I did a search on SI for QLT and posted to the various boards that came up in my search about the positive Phase 3. Bad idea on my part. If I have made the same mistake here - I apologize in advance. regards, John McCarthy